Hepatitis C in Developing Countries

Current and Future Challenges

Nonfiction, Science & Nature, Science, Biological Sciences, Microbiology, Health & Well Being, Medical
Cover of the book Hepatitis C in Developing Countries by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128032343
Publisher: Elsevier Science Publication: November 23, 2017
Imprint: Academic Press Language: English
Author:
ISBN: 9780128032343
Publisher: Elsevier Science
Publication: November 23, 2017
Imprint: Academic Press
Language: English

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

  • Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma
  • Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6
  • Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

More books from Elsevier Science

Cover of the book Foodborne Diseases by
Cover of the book Ecological Design of Smart Home Networks by
Cover of the book Psychology and Climate Change by
Cover of the book Understanding Pulmonary Pathology by
Cover of the book Programming Lego Mindstorms NXT by
Cover of the book Understanding Librarians by
Cover of the book Structural Vibration by
Cover of the book The Foundations of Vacuum Coating Technology by
Cover of the book Laser-Induced Breakdown Spectroscopy by
Cover of the book Mutagenicity: Assays and Applications by
Cover of the book Modeling Gravity Hazards from Rockfalls to Landslides by
Cover of the book Sustainable Construction Materials by
Cover of the book Recombinant DNA and Genetic Experimentation by
Cover of the book Recycling of Polyurethane Foams by
Cover of the book IFRS 9 and CECL Credit Risk Modelling and Validation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy